UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Annual review of neuroscience, ISSN 0147-006X, 07/2011, Volume 34, Issue 1, pp. 105 - 130
Nucleus accumbens | Dopamine | Interpeduncular nucleus | Ventral tegmental area | Habenula | Synaptic plasticity | Limbic System - pathology | Receptors, Nicotinic - metabolism | Substance Withdrawal Syndrome - etiology | Humans | Cerebral Cortex - pathology | Neuronal Plasticity - drug effects | Nicotine - adverse effects | Substance Withdrawal Syndrome - pathology | Animals | Neuronal Plasticity - physiology | Neurons - physiology | Reward | Behavior, Addictive - physiopathology | Substance Withdrawal Syndrome - psychology | Dopamine - metabolism | Psychological aspects | Physiological aspects | Health aspects | Nicotine | Tobacco habit | Addictions | Neurons | Index Medicus | interpeduncular nucleus | synaptic plasticity | nucleus accumbens | ventral tegmental area | habenula | dopamine
Journal Article
Nature neuroscience, ISSN 1097-6256, 07/2019, Volume 22, Issue 7, pp. 1053 - 1056
Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Receptors, Glutamate - analysis | Naloxone - toxicity | Synaptic Transmission - physiology | Receptors, N-Methyl-D-Aspartate - analysis | Mice, Inbred C57BL | Male | Random Allocation | Receptors, Tumor Necrosis Factor, Type I - genetics | Cytokines - physiology | Animals | Microglia - physiology | Neuronal Plasticity | Receptors, Tumor Necrosis Factor, Type I - physiology | Social Behavior | Tumor Necrosis Factor-alpha - physiology | Female | Mice | Substance Withdrawal Syndrome - physiopathology | Substance Withdrawal Syndrome - psychology | Morphine - adverse effects | Adaptation, Psychological | Habenula - physiology | Neuroplasticity | Development and progression | Drug withdrawal symptoms | Cytokines | Health aspects | Analysis | Adaptations | Tumor necrosis factor receptors | Behavioral plasticity | Habenula | Synaptic plasticity | Morphine | Tumor necrosis factor-TNF | Inhibition (psychology) | Glutamatergic transmission | Tumor necrosis factor-α | Microglia | Index Medicus | Animal genetics | Neurons and Cognition | Neurobiology | Synaptic Transmission | Life Sciences | Genetics | Pulmonology and respiratory tract | Cardiology and cardiovascular system | Pharmaceutical sciences | Receptors, Glutamate | Receptors, Tumor Necrosis Factor, Type I | Biochemistry, Molecular Biology | Receptors, N-Methyl-D-Aspartate | Pharmacology | Substance Withdrawal Syndrome | Tumor Necrosis Factor-alpha | Psychiatrics and mental health | Human health and pathology | Naloxone | Molecular biology
Journal Article
BJU international, ISSN 1464-4096, 03/2015, Volume 115, Issue 3, pp. 373 - 380
castration‐resistant prostate cancer | androgen receptor targeting | hormone therapy | androgen receptor gene F876L mutation | enzalutamide | antiandrogen withdrawal syndrome | castration-resistant prostate cancer | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Phenylthiohydantoin - adverse effects | Phenylthiohydantoin - therapeutic use | Substance Withdrawal Syndrome - etiology | Prostatic Neoplasms, Castration-Resistant - blood | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Antineoplastic Agents - therapeutic use | Prostatic Neoplasms, Castration-Resistant - drug therapy | Phenylthiohydantoin - analogs & derivatives | Prostate-Specific Antigen - blood | Prostatic Neoplasms, Castration-Resistant - pathology | Antineoplastic Agents - adverse effects | Substance Withdrawal Syndrome - blood | Aged, 80 and over | Androgen Antagonists - therapeutic use | Aged | Kallikreins - blood | Retrospective Studies | Androgen Antagonists - adverse effects | Prostate cancer | Analysis | Medical research | Metastasis | Index Medicus
Journal Article
Nature communications, ISSN 2041-1723, 12/2019, Volume 10, Issue 1, pp. 1238 - 1238
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Humans | Septal Nuclei - pathology | Male | Optogenetics | Septal Nuclei - cytology | Substance Withdrawal Syndrome - pathology | Behavior, Animal | Septal Nuclei - metabolism | Substance Withdrawal Syndrome - metabolism | Central Amygdaloid Nucleus - physiopathology | Corticotropin-Releasing Hormone - genetics | Neurons - metabolism | Neural Pathways - physiopathology | Septal Nuclei - physiopathology | Alcoholism - physiopathology | Behavior, Addictive - physiopathology | Disease Models, Animal | Alcoholism - pathology | Central Amygdaloid Nucleus - cytology | Rats | Corticotropin-Releasing Hormone - metabolism | Central Amygdaloid Nucleus - pathology | Animals | Neural Pathways - metabolism | Central Amygdaloid Nucleus - metabolism | Substance Withdrawal Syndrome - physiopathology | Substance Withdrawal Syndrome - psychology | Drug addiction | Deactivation | Amygdala | Neurons | Drinking behavior | Withdrawal | Stria terminalis | Inactivation | Corticotropin-releasing hormone | Alcohol use | Alcohols | Addiction | Inhibition | Index Medicus
Journal Article
Neurology, ISSN 0028-3878, 08/2010, Volume 75, Issue 9, pp. 831 - 833
Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Neurology | Biological and medical sciences | Malformations of the nervous system | Medical sciences | Multiple Sclerosis, Relapsing-Remitting - pathology | Immune Reconstitution Inflammatory Syndrome - etiology | Natalizumab | Substance Withdrawal Syndrome - etiology | Immune Reconstitution Inflammatory Syndrome - diagnosis | Multiple Sclerosis, Relapsing-Remitting - drug therapy | Humans | Antibodies, Monoclonal - adverse effects | Substance Withdrawal Syndrome - pathology | Immune Reconstitution Inflammatory Syndrome - pathology | Antibodies, Monoclonal, Humanized | Antibodies, Monoclonal - administration & dosage | Adult | Female | Substance Withdrawal Syndrome - diagnosis | Index Medicus | Abridged Index Medicus
Journal Article
ChemMedChem, ISSN 1860-7179, 08/2017, Volume 12, Issue 16, pp. 1408 - 1416
structural similarity | Cannabis sativa | virtual screening | computational chemistry | medicinal chemistry | Caco-2 Cells | Resorcinols - pharmacokinetics | Receptor, Cannabinoid, CB2 - agonists | Humans | Half-Life | Substance Withdrawal Syndrome - drug therapy | Cannabis - metabolism | Blood-Brain Barrier - drug effects | Resorcinols - therapeutic use | Blood-Brain Barrier - metabolism | Substance Withdrawal Syndrome - pathology | Resorcinols - pharmacology | Receptor, Cannabinoid, CB1 - metabolism | Receptor, Cannabinoid, CB2 - metabolism | Cannabis - chemistry | Animals | Receptor, Cannabinoid, CB1 - agonists | Substance Withdrawal Syndrome - metabolism | Resorcinols - chemistry | Cell Membrane Permeability - drug effects | Drug Design | Ligands | Mice | Marijuana | Health aspects | Index Medicus
Journal Article
7.
Full Text
Neonatal withdrawal syndrome after chronic maternal consumption of 4-methylethcathinone
Forensic science international, ISSN 0379-0738, 2014, Volume 245, pp. e33 - e35
Pathology | Meconium | Hair testing | Neonatal withdrawal syndrome | 4-Methylethcathinone | Life Sciences & Biomedicine | Medicine, Legal | Legal Medicine | Science & Technology | Pregnancy | Propiophenones - adverse effects | Maternal-Fetal Exchange | Humans | Designer Drugs - adverse effects | Amphetamines - adverse effects | Female | Neonatal Abstinence Syndrome - etiology | Infant, Newborn | Substance-Related Disorders - complications | Mephedrone | Birth defects | Research | Maternal-fetal exchange | Hypertension | Hair | Ecstasy | Urine | Consumption | Cardiac arrhythmia | Dopamine | Medical treatment | Methamphetamine | Hepatitis | Drug dosages | Heroin | Drugs | Websites | Segments | Markets | Liquid chromatography | Exposure | Index Medicus
Journal Article
Neuroreport, ISSN 0959-4965, 04/2017, Volume 28, Issue 6, pp. 339 - 347
thermal hyperalgesia | ionized calcium-binding adapter molecule 1 | brain-derived neurotrophic factor | minocycline | pain hypersensitivity | P2X4 receptor | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Hyperalgesia - chemically induced | Microglia - metabolism | Pain Threshold - physiology | Spinal Cord - drug effects | Spinal Cord - metabolism | Minocycline - pharmacology | Analgesics, Non-Narcotic - pharmacology | Substance Withdrawal Syndrome - drug therapy | Male | Hyperalgesia - pathology | Substance Withdrawal Syndrome - pathology | Substance Withdrawal Syndrome - metabolism | Spinal Cord - pathology | Microglia - pathology | Pain Threshold - drug effects | Brain-Derived Neurotrophic Factor - metabolism | Microfilament Proteins - metabolism | Nicotinic Agonists - toxicity | Disease Models, Animal | Calcium-Binding Proteins - metabolism | Hyperalgesia - metabolism | Microglia - drug effects | Hot Temperature | Nicotine - toxicity | Rats, Sprague-Dawley | Animals | Hyperalgesia - drug therapy | Receptors, Purinergic P2X4 - metabolism | Index Medicus
Journal Article
Neurotoxicity research, ISSN 1029-8428, 10/2017, Volume 32, Issue 3, pp. 509 - 517
Neurochemistry | Neurology | Neurosciences | Biomedicine | BDNF | Tissue plasminogen activator | Neurobiology | Furin | proBDNF | Pharmacology/Toxicology | Opioid abuse | Cell Biology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Neurons - pathology | Frontal Lobe - metabolism | Tissue Plasminogen Activator - metabolism | Male | Morphine - toxicity | Corpus Striatum - metabolism | Substance Withdrawal Syndrome - pathology | Substance Withdrawal Syndrome - metabolism | Matrix Metalloproteinase 7 - metabolism | Brain-Derived Neurotrophic Factor - metabolism | Neurons - metabolism | Neurons - drug effects | Corpus Striatum - pathology | Furin - metabolism | Cells, Cultured | Matrix Metalloproteinase 3 - metabolism | Rats, Sprague-Dawley | Protein Precursors - metabolism | Morphine Dependence - metabolism | Morphine Dependence - pathology | Animals | Frontal Lobe - drug effects | Corpus Striatum - drug effects | Narcotics - toxicity | Frontal Lobe - pathology | Morphine | Proteases | Neurons | Analysis | Neurophysiology | Index Medicus | opioid abuse | tissue plasminogen activator | furin
Journal Article
Neuropharmacology, ISSN 0028-3908, 06/2016, Volume 105, pp. 520 - 532
Methamphetamine withdrawal | Anxiety | Oxytocin | CRF | μ-opioid receptor | Pharmacology & Pharmacy | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Neurons - pathology | Amygdala - drug effects | Methamphetamine - adverse effects | Male | Amphetamine-Related Disorders - pathology | Receptors, Dopamine D2 - metabolism | Corpus Striatum - metabolism | Substance Withdrawal Syndrome - pathology | Substance Withdrawal Syndrome - metabolism | Central Nervous System Stimulants - adverse effects | Septum of Brain - pathology | Neurons - metabolism | Corticosterone - blood | Neurons - drug effects | Anxiety - metabolism | Corpus Striatum - pathology | Amphetamine-Related Disorders - metabolism | Disease Models, Animal | Receptors, Opioid, mu - metabolism | Mice, Inbred C57BL | Amygdala - metabolism | Proto-Oncogene Proteins c-fos - metabolism | Septum of Brain - metabolism | Septum of Brain - drug effects | Random Allocation | Amygdala - pathology | Corticotropin-Releasing Hormone - metabolism | Anxiety - pathology | Receptors, Oxytocin - metabolism | Animals | Methamphetamine - administration & dosage | Corpus Striatum - drug effects | Amphetamine-Related Disorders - complications | Central Nervous System Stimulants - administration & dosage | Substance Withdrawal Syndrome - psychology | Anxiety - etiology | Index Medicus
Journal Article